Global Tuberculosis Testing and Diagnostics Market Size, Status and Forecast 2024-2031

Report ID: 923061 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Smear Microscopy
        1.2.3 Nucleic Acid Testing
        1.2.4 Radiography
        1.2.5 Tuberculin Skin Test (TST)
        1.2.6 Interferon Gamma Released Assay (IGRA)
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Tuberculosis Testing and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals and Clinics
        1.3.3 Diagnostic Laboratories
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Tuberculosis Testing and Diagnostics Market Perspective (2016-2027)
    2.2 Tuberculosis Testing and Diagnostics Growth Trends by Regions
        2.2.1 Tuberculosis Testing and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Tuberculosis Testing and Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 Tuberculosis Testing and Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 Tuberculosis Testing and Diagnostics Industry Dynamic
        2.3.1 Tuberculosis Testing and Diagnostics Market Trends
        2.3.2 Tuberculosis Testing and Diagnostics Market Drivers
        2.3.3 Tuberculosis Testing and Diagnostics Market Challenges
        2.3.4 Tuberculosis Testing and Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue
        3.1.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Tuberculosis Testing and Diagnostics Revenue
    3.4 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio
        3.4.1 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Testing and Diagnostics Revenue in 2020
    3.5 Tuberculosis Testing and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
    3.7 Date of Enter into Tuberculosis Testing and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis Testing and Diagnostics Breakdown Data by Type
    4.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2022-2027)

5 Tuberculosis Testing and Diagnostics Breakdown Data by Application
    5.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Tuberculosis Testing and Diagnostics Market Size (2016-2027)
    6.2 North America Tuberculosis Testing and Diagnostics Market Size by Type
        6.2.1 North America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
    6.3 North America Tuberculosis Testing and Diagnostics Market Size by Application
        6.3.1 North America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
    6.4 North America Tuberculosis Testing and Diagnostics Market Size by Country
        6.4.1 North America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Tuberculosis Testing and Diagnostics Market Size (2016-2027)
    7.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type
        7.2.1 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
    7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Application
        7.3.1 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
    7.4 Europe Tuberculosis Testing and Diagnostics Market Size by Country
        7.4.1 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Tuberculosis Testing and Diagnostics Market Size (2016-2027)
    9.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Type
        9.2.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Application
        9.3.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America Tuberculosis Testing and Diagnostics Market Size by Country
        9.4.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Tuberculosis Testing and Diagnostics Introduction
        11.1.4 Roche Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Thermo Fischer Scientific
        11.2.1 Thermo Fischer Scientific Company Details
        11.2.2 Thermo Fischer Scientific Business Overview
        11.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Introduction
        11.2.4 Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.2.5 Thermo Fischer Scientific Recent Development
    11.3 Becton Dickinson
        11.3.1 Becton Dickinson Company Details
        11.3.2 Becton Dickinson Business Overview
        11.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Introduction
        11.3.4 Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.3.5 Becton Dickinson Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Details
        11.4.2 Abbott Business Overview
        11.4.3 Abbott Tuberculosis Testing and Diagnostics Introduction
        11.4.4 Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.4.5 Abbott Recent Development
    11.5 Hologic
        11.5.1 Hologic Company Details
        11.5.2 Hologic Business Overview
        11.5.3 Hologic Tuberculosis Testing and Diagnostics Introduction
        11.5.4 Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.5.5 Hologic Recent Development
    11.6 Qiagen
        11.6.1 Qiagen Company Details
        11.6.2 Qiagen Business Overview
        11.6.3 Qiagen Tuberculosis Testing and Diagnostics Introduction
        11.6.4 Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.6.5 Qiagen Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Tuberculosis Testing and Diagnostics Introduction
        11.7.4 Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.7.5 Sanofi Recent Development
    11.8 Oxford Immunotec
        11.8.1 Oxford Immunotec Company Details
        11.8.2 Oxford Immunotec Business Overview
        11.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Introduction
        11.8.4 Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.8.5 Oxford Immunotec Recent Development
    11.9 BioMerieux
        11.9.1 BioMerieux Company Details
        11.9.2 BioMerieux Business Overview
        11.9.3 BioMerieux Tuberculosis Testing and Diagnostics Introduction
        11.9.4 BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.9.5 BioMerieux Recent Development
    11.10 Par Sterile
        11.10.1 Par Sterile Company Details
        11.10.2 Par Sterile Business Overview
        11.10.3 Par Sterile Tuberculosis Testing and Diagnostics Introduction
        11.10.4 Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.10.5 Par Sterile Recent Development
    11.11 Bio-Rad Laboratories
        11.11.1 Bio-Rad Laboratories Company Details
        11.11.2 Bio-Rad Laboratories Business Overview
        11.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Introduction
        11.11.4 Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.11.5 Bio-Rad Laboratories Recent Development
    11.12 Akonni Biosystems
        11.12.1 Akonni Biosystems Company Details
        11.12.2 Akonni Biosystems Business Overview
        11.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Introduction
        11.12.4 Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.12.5 Akonni Biosystems Recent Development
    11.13 Cepheid
        11.13.1 Cepheid Company Details
        11.13.2 Cepheid Business Overview
        11.13.3 Cepheid Tuberculosis Testing and Diagnostics Introduction
        11.13.4 Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.13.5 Cepheid Recent Development
    11.14 Siemens Healthineer
        11.14.1 Siemens Healthineer Company Details
        11.14.2 Siemens Healthineer Business Overview
        11.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Introduction
        11.14.4 Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.14.5 Siemens Healthineer Recent Development
    11.15 Hain Lifescience
        11.15.1 Hain Lifescience Company Details
        11.15.2 Hain Lifescience Business Overview
        11.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Introduction
        11.15.4 Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.15.5 Hain Lifescience Recent Development
    11.16 Epistem
        11.16.1 Epistem Company Details
        11.16.2 Epistem Business Overview
        11.16.3 Epistem Tuberculosis Testing and Diagnostics Introduction
        11.16.4 Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.16.5 Epistem Recent Development
    11.17 Creative Diagnostics
        11.17.1 Creative Diagnostics Company Details
        11.17.2 Creative Diagnostics Business Overview
        11.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Introduction
        11.17.4 Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021)
        11.17.5 Creative Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Smear Microscopy
    Table 3. Key Players of Nucleic Acid Testing
    Table 4. Key Players of Radiography
    Table 5. Key Players of Tuberculin Skin Test (TST)
    Table 6. Key Players of Interferon Gamma Released Assay (IGRA)
    Table 7. Key Players of Others
    Table 8. Global Tuberculosis Testing and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Tuberculosis Testing and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Tuberculosis Testing and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Tuberculosis Testing and Diagnostics Market Share by Regions (2016-2021)
    Table 12. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Tuberculosis Testing and Diagnostics Market Share by Regions (2022-2027)
    Table 14. Tuberculosis Testing and Diagnostics Market Trends
    Table 15. Tuberculosis Testing and Diagnostics Market Drivers
    Table 16. Tuberculosis Testing and Diagnostics Market Challenges
    Table 17. Tuberculosis Testing and Diagnostics Market Restraints
    Table 18. Global Tuberculosis Testing and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Tuberculosis Testing and Diagnostics Market Share by Players (2016-2021)
    Table 20. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2020)
    Table 21. Ranking of Global Top Tuberculosis Testing and Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Tuberculosis Testing and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
    Table 25. Date of Enter into Tuberculosis Testing and Diagnostics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2016-2021)
    Table 29. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Tuberculosis Testing and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2016-2021)
    Table 33. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Tuberculosis Testing and Diagnostics Product
    Table 68. Roche Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 69. Roche Recent Development
    Table 70. Thermo Fischer Scientific Company Details
    Table 71. Thermo Fischer Scientific Business Overview
    Table 72. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product
    Table 73. Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 74. Thermo Fischer Scientific Recent Development
    Table 75. Becton Dickinson Company Details
    Table 76. Becton Dickinson Business Overview
    Table 77. Becton Dickinson Tuberculosis Testing and Diagnostics Product
    Table 78. Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 79. Becton Dickinson Recent Development
    Table 80. Abbott Company Details
    Table 81. Abbott Business Overview
    Table 82. Abbott Tuberculosis Testing and Diagnostics Product
    Table 83. Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 84. Abbott Recent Development
    Table 85. Hologic Company Details
    Table 86. Hologic Business Overview
    Table 87. Hologic Tuberculosis Testing and Diagnostics Product
    Table 88. Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 89. Hologic Recent Development
    Table 90. Qiagen Company Details
    Table 91. Qiagen Business Overview
    Table 92. Qiagen Tuberculosis Testing and Diagnostics Product
    Table 93. Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 94. Qiagen Recent Development
    Table 95. Sanofi Company Details
    Table 96. Sanofi Business Overview
    Table 97. Sanofi Tuberculosis Testing and Diagnostics Product
    Table 98. Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 99. Sanofi Recent Development
    Table 100. Oxford Immunotec Company Details
    Table 101. Oxford Immunotec Business Overview
    Table 102. Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 103. Oxford Immunotec Recent Development
    Table 104. BioMerieux Company Details
    Table 105. BioMerieux Business Overview
    Table 106. BioMerieux Tuberculosis Testing and Diagnostics Product
    Table 107. BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 108. BioMerieux Recent Development
    Table 109. Par Sterile Company Details
    Table 110. Par Sterile Business Overview
    Table 111. Par Sterile Tuberculosis Testing and Diagnostics Product
    Table 112. Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 113. Par Sterile Recent Development
    Table 114. Bio-Rad Laboratories Company Details
    Table 115. Bio-Rad Laboratories Business Overview
    Table 116. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product
    Table 117. Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 118. Bio-Rad Laboratories Recent Development
    Table 119. Akonni Biosystems Company Details
    Table 120. Akonni Biosystems Business Overview
    Table 121. Akonni Biosystems Tuberculosis Testing and Diagnostics Product
    Table 122. Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 123. Akonni Biosystems Recent Development
    Table 124. Cepheid Company Details
    Table 125. Cepheid Business Overview
    Table 126. Cepheid Tuberculosis Testing and Diagnostics Product
    Table 127. Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 128. Cepheid Recent Development
    Table 129. Siemens Healthineer Company Details
    Table 130. Siemens Healthineer Business Overview
    Table 131. Siemens Healthineer Tuberculosis Testing and Diagnostics Product
    Table 132. Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 133. Siemens Healthineer Recent Development
    Table 134. Hain Lifescience Company Details
    Table 135. Hain Lifescience Business Overview
    Table 136. Hain Lifescience Tuberculosis Testing and Diagnostics Product
    Table 137. Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 138. Hain Lifescience Recent Development
    Table 139. Epistem Company Details
    Table 140. Epistem Business Overview
    Table 141. Epistem Tuberculosis Testing and Diagnostics Product
    Table 142. Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 143. Epistem Recent Development
    Table 144. Creative Diagnostics Company Details
    Table 145. Creative Diagnostics Business Overview
    Table 146. Creative Diagnostics Tuberculosis Testing and Diagnostics Product
    Table 147. Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2016-2021) & (US$ Million)
    Table 148. Creative Diagnostics Recent Development
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tuberculosis Testing and Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. Smear Microscopy Features
    Figure 3. Nucleic Acid Testing Features
    Figure 4. Radiography Features
    Figure 5. Tuberculin Skin Test (TST) Features
    Figure 6. Interferon Gamma Released Assay (IGRA) Features
    Figure 7. Others Features
    Figure 8. Global Tuberculosis Testing and Diagnostics Market Share by Application: 2020 VS 2027
    Figure 9. Hospitals and Clinics Case Studies
    Figure 10. Diagnostic Laboratories Case Studies
    Figure 11. Others Case Studies
    Figure 12. Tuberculosis Testing and Diagnostics Report Years Considered
    Figure 13. Global Tuberculosis Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Tuberculosis Testing and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Tuberculosis Testing and Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 16. Global Tuberculosis Testing and Diagnostics Market Share by Regions (2022-2027)
    Figure 17. Global Tuberculosis Testing and Diagnostics Market Share by Players in 2020
    Figure 18. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Testing and Diagnostics Revenue in 2020
    Figure 20. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 21. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 22. North America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
    Figure 24. North America Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
    Figure 25. North America Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
    Figure 26. United States Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
    Figure 30. Europe Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
    Figure 31. Europe Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
    Figure 32. Germany Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Region (2016-2027)
    Figure 42. China Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
    Figure 50. Latin America Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
    Figure 51. Latin America Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
    Figure 52. Mexico Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Country (2016-2027)
    Figure 58. Turkey Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Tuberculosis Testing and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Roche Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 62. Thermo Fischer Scientific Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 63. Becton Dickinson Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 64. Abbott Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 65. Hologic Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 66. Qiagen Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 67. Sanofi Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 68. Oxford Immunotec Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 69. BioMerieux Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 70. Par Sterile Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 72. Akonni Biosystems Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 73. Cepheid Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 74. Siemens Healthineer Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 75. Hain Lifescience Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 76. Epistem Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 77. Creative Diagnostics Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2016-2021)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics
Frequently Asked Questions
Tuberculosis Testing and Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tuberculosis Testing and Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tuberculosis Testing and Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports